Tag: glass_particles

• Fresenius Kabi Recalls Tyenne® Injection Vials Due to Glass Particles

  12 Aug 2026 4:47 p.m. · Source: US Food and Drug Administration

  Fresenius Kabi is recalling Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL vials nationwide due to glass particles, posing risks including blood clots and organ damage. The affected lot was shipped between March 3 and March 25, 2026.

  HealthBusinessMedical ScienceLegalEconomy Product RecallPharmaceuticalsFresenius KabiTyenneTocilizumab-aazgGlass ParticlesDrug SafetyFood RecallsFDADrugs

• Fresenius Kabi Recalls Tyenne Injection Vials Due to Glass Particles

  12 Aug 2026 8:32 a.m. · Source: US Food and Drug Administration

  Fresenius Kabi has issued a nationwide recall for one lot of Tyenne Injection 400 mg/20 mL vials. The recall is due to the presence of glass particles, posing serious health risks including blood clots and organ damage.

  HealthBusinessMedical ScienceFederal Government Fresenius KabiTyenne InjectionProduct RecallGlass ParticlesFDADrug SafetyPharmaceuticalsFood RecallsDrugs

• Sun Pharma Recalls Cancer Drug Over Glass Particles

  14 May 2026 4:17 p.m. · Source: US Food and Drug Administration

  Sun Pharma is recalling one batch of DOXOrubicin Hydrochloride Liposome Injection 50mg/25 mL in the U.S. due to glass particles. The drug, used for various cancers, poses risks of irritation and blood clots, though no adverse events have been reported.

  HealthBusinessMedical ScienceFederal GovernmentLegal Product RecallSun Pharmaceutical IndustriesDOXOrubicin Hydrochloride Liposome InjectionGlass particlesPharmaceuticalsCancerFDAFood RecallsDrugs

← Back to latest